NATCO Pharma Limited announces launch of Semaglutide Injection (multi dose vials) in the India market tomorrow on Day 1 of ...

One lot of an injection drug meant to help patients deal with leukemia has been recalled on concerns it might damage or kill the patient. That’s not overstatement, but, rather, the summary of the ...

Multi-dose vials will be launched at MRP of Rs 1,290 per month for 2 mg/1.5ml & 4mg/3ml and MRP of Rs 1,750 for 8mg/3ml, said Natco Pharma ...

The approval expands Amneal’s injectables portfolio with an essential medicine used in hospitals for emergency and perioperative care. Epinephrine is a non-selective alpha and beta adrenergic agonist.

Mylan announced that its subsidiary Agila Specialties is conducting a nationwide recall of 10 lots of Etomidate Injection 2mg/mL. This recall was initiated due to the potential for small black ...

Only ready-to-use liquid format of bivalirudin on the market Does not require reconstitution, dilution or mixing, which helps increase efficiency for hospitals and healthcare providers DUBLIN, July 18 ...

To date, the Company has not received reports of any adverse events related to this recall. Fresenius Kabi is voluntarily recalling 7 lots of Sodium Acetate Injection, USP, 400mEq/100mL (4mEq/mL), ...

NATCO Pharma announced the launch of Semaglutide Injection (multi dose vials) in India market tomorrow on Day 1 of patent expiry.